Zydus Lifesciences’ arm incorporates wholly owned subsidiary in USA

14 Jul 2025 Evaluate

Zydus Lifesciences’ wholly owned subsidiary -- Zydus Pharmaceuticals USA Inc., USA, (ZPUI) has incorporated a wholly owned subsidiary in the name of a Zylidac Bio LLC (Zylidac) in the United States of America on July 11, 2025, and is yet to commence its business operation. The immediate objective of incorporation of Zylidac is to acquire the target assets of Agenus.

Earlier, ZPUI has entered into a definitive agreement with Zylidac, and Agenus Inc., USA (collectively referred to as ‘Agenus’), to acquire, directly or through its affiliates, two U.S. based biologics manufacturing facilities of Agenus, one in Emeryville, CA and another in Berkeley, CA (‘the target assets’). 

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×